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How is a Specialist Depression Service effective for persistent moderate to 
severe depressive disorder?: A qualitative study of service user experience. 
 
Abstract 
 
Background.  A specialist depression service (SDS) offering collaborative 
pharmacological and cognitive behaviour therapy treatment for persistent depressive 
disorder showed effectiveness against depression symptoms versus usual 
community based multidisciplinary care in a randomised controlled trial (RCT) in 
specialist mental health services in England. However, there is uncertainty 
concerning how specialist depression services effect such change. The current study 
aimed to  evaluate the factors which may explain the greater effectiveness of SDS 
compared to Treatment as Usual (TAU) by exploring the experience of the RCT 
participants .  
Methods. Qualitative audiotaped and transcribed semi-structured interviews were 
conducted 12-18 months after baseline with 21 service users (12 SDS, 9 TAU arms) 
drawn from all three sites. Inductive thematic analysis using a grounded approach 
contrasted the experiences of SDS with TAU participants. 
Results. Four themes emerged in relation to service user experience: 1. Specific 
treatment components of the SDS: which included sub-themes of the management 
of medication change, explaining and developing treatment strategies, setting 
realistic expectations, and person-centred and holistic approach; 2. Individual 
qualities of SDS clinicians; 3. Collaborative team context in SDS: which included 
sub-themes of communication between healthcare professionals, and continuity of 
team members; 4. Accessibility to SDS: which included sub-themes of flexibility of 
locations, frequent consultation as reinforcement, gradual pace of treatment, and 
challenges of returning to usual care. 
Conclusions. The study  uncovered important mechanisms and contextual factors 
in the SDS that service users experience as different from TAU, and which may 
explain the greater effectiveness of the SDS:  the technical expertise of the 
healthcare professionals, personal qualities of clinicians, teamwork, gradual pace of 
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care, accessibility and managing service transitions. Usual care in other specialist 
mental health services may share many of the features from the SDS.  
Trial Registration: “Trial of the Clinical and Cost Effectiveness of a Specialist 
Expert Mood Disorder Team for Refractory Unipolar Depressive Disorder” was 
registered in www.ClinicalTrials.gov (NCT01047124) on 12-01-2010 and the ISRCTN 
registry (ISRCTN10963342) on 25-11-2015 (retrospectively registered). 
 
 
Keywords: Depression, Cognitive Behavioural Therapy, Pharmacological Therapy, Service 
User Experience, Qualitative study 
 
 
Background  
 
Major depressive disorder is experienced by up to 15% of people in high income 
countries at least once in their lifetime [1]. It has been identified as the second leading 
cause of years lived with disability in the world [2]. Furthermore, recurrence of major 
depressive disorder is high, rising from a rate of 60% recurrence 5 years after an 
episode of depression to 85% after 15 years [3].  
 
Combined pharmacotherapy and psychological treatments delivered by specialist 
multi-professional teams are widely recommended [4]. This collaborative care 
approach is characterised by joint assessments by psychiatrists and psychological 
therapists, and the development of structured management plans according to 
protocols for both psychotherapy and pharmacology based on NICE Guidelines for 
depression (2009) [5]. However, only a small number of randomised controlled trials 
(RCTs) have examined the effectiveness of such a collaborative treatment service for 
persistent, chronic or treatment resistant moderate-to-severe depressive disorder[e.g. 
6]. In our primary study, a large scale RCT of a Specialist Depression Service (SDS) 
providing pharmacotherapy and psychological treatment from a collaborative 
specialist team [7] showed a significant reduction in depression symptoms after 18 
months[8]. However, there is uncertainty about the factors which may contribute to 
these improved outcomes for people experiencing severe and recurring depression 
[9] and service users’ experience of these. 
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There is little research evidence to date examining the factors that influence the 
effectiveness of collaborative care models for depression. The NICE 2017 draft 
guidelines for depression [10] includes an analysis showing that improved outcomes 
from collaborative care for depression were mediated by having stepped care where 
another treatment is used if the first is not responsive, decision-support between the 
psychiatrist and psychotherapist, and having a medication algorithm. Longer illness 
duration is a robust predictor of poor outcome in antidepressant-placebo drug trials 
and combinations of psychotherapy and antidepressant treatment studies [11, 12, 13, 
14]. Length of therapeutic intervention appears to be an important factor for longer-
term remission from depression symptoms [15], and one trial has found that more than 
16 sessions of either CBT or psychodynamic supportive therapy were needed to 
achieve remission [16].  In psychotherapy research, therapeutic alliance when rated 
by the patient and adherence by the therapist to the treatment manual have been 
found to be a moderator of outcomes [17]. Together, these findings suggest the future 
design of services for people with recurrent depression should aim to foster a longer-
term and collaborative approach to building therapeutic relationships. 
 
Qualitative methods have been shown to provide a useful approach to understanding 
participants’ perceptions and experiences of an intervention and to identify the active 
ingredients of complex and multi-faceted mental health services [18, 19, 20, 21]. 
Romakkaniemi and Kilpelainen [22] analysed the experiences of two service users 
with depression through their written blogs and found four themes: a confident working 
relationship, time and hiatus for finding one’s own authenticity, successful timing of 
interventions and a holistic view of life. However, this study did not examine the 
experience of a single service, rather their experience of multiple services over time.  
 
The aims of this qualitative study into service user experiences were to: 
 Obtain service user views on their experience of either the SDS or Treatment 
as Usual (TAU) as part of a large RCT 
 Identify the features of the SDS intervention that were experienced as beneficial 
 Compare the experience of those in different arms of the study 
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Methods 
SDS Trial Design 
The SDS treatment groups received a collaborative care approach between patient, 
psychiatrist and cognitive behaviour therapist, and, where clinically indicated, contact 
with the patient’s General Practitioner (GP) and community mental health teams, 
voluntary sector organisations, family and friends and employers. The SDS 
collaborative approach began with a joint assessment between service user, 
psychiatrist and CBT therapist. Follow up sessions using the same format were 
conducted at 3,6,9 and 12 months. The intervention was characterised by optimised 
pharmacotherapy (meeting individually with the psychiatrist initially fortnightly tapering 
to monthly and three monthly once optimised). Alongside this was weekly Beckian 
CBT with an option for MBCT as a relapse prevention strategy. From month 10 there 
was a gradual transition to usual care either primary care or secondary care 
community teams after 13 months (range 12-15). The SDS groups also took an active 
social inclusion and recovery stance [23] and had links with local social inclusion 
initiatives (i.e. vocational, educational and back to work and self-help support 
networks). The services aimed to deliver a collaborative and integrated 
psychobiosocial model of treatment [24] in which equal importance is given to 
medication and psychosocial interventions as treatments of potential benefit, and the 
initial treatment rationale presented explicitly articulated the reasons for using each in 
combination. All treatments were National Institute for Health and Care Excellence 
(NICE) –recommended [4] and delivered by staff with a high level of training and 
clinical expertise in treating depression.   
 
TAU was directed by a consultant psychiatrist and consisted of pharmacotherapy, 
sometimes augmented by psychological interventions but without co-ordination or joint 
reviews and assessments between healthcare professionals[7;8].  
  
Study sites 
The Specialised Depression Service was implemented in the three free to the public 
specialist mental health services operated by the National Health Service in England 
in Nottinghamshire, Cambridgeshire and Derbyshire.   
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Participants in the RCT      
The RCT recruited 187 participants with moderate to severe depression  from the three 
sites as follows Nottingham (137), Derby (21) and Cambridge (29): 93 were assigned 
to SDS and 94 to TAU. Figure 1 shows the flow of participants through the trial. 
Inclusion criteria for the RCT were a primary diagnosis of major depressive disorder; 
continuing contact with specialist mental health services after six months, score 16 or 
above on the 17-item Hamilton Rating Scale for Depression (HRSD) [25] and 60 or 
below on the Global Assessment of Functioning (GAF) [26]. Exclusion criteria such 
that patients were excluded if they were in receipt of emergency care for suicide risk, 
homicide risk or severe neglect, but patients were not excluded because of such risks 
provided these risks were adequately contained in their current care setting and the 
primary medical responsibility for care was with the referral team. They were also 
excluded if they were pregnant, did not speak fluent English or had depression 
secondary to another primary psychiatric or organic condition.  Patients were recruited 
from the existing caseloads of secondary care mental health teams at each site. Table 
1 shows sociodemographic and clinical characteristics of the sample in the RCT at 
baseline, primary outcome results from baseline to 18 months, and contacts with 
psychiatrists and psychotherapists over 18 months (see [8] for more details).  The 
cohort recruited was substantially more depressed, functionally impaired, and had 
both depression symptoms and treatment for longer than required for entry to the 
study.  As such, they represent a group that presents challenges for treatment and 
management and that frequently have poor outcomes. 
 
Participants in the Qualitative Study   
Semi-structured interviews were conducted by MB, an experienced qualitative 
interviewer, with a maximum variance sample of service users from both the SDS 
(n=12) and TAU l arms (n=9) at 12-18 months after baseline at the end of SDS 
treatment (total sample n=21)(Table 2).  The criteria for achieving the maximum 
variance sample were: study site, dropping out of follow-up, dropping out of treatment, 
completing treatment and completing of follow up, gender, age bands (18-30, 31-45, 
46-55, over 55years old at baseline), marital status, living on own or someone else, 
having a children or not, completed education at 18 or not, in work or not, time since 
first diagnosis, current medical comorbidity or not, other current mental comorbidity or 
not, moderately severe or severe at baseline, whether or not has psychotherapist at 
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baseline, whether or not has care coordinator at baseline. 21 participants were 
selected for interview as this was the number required to check off all of these criteria. 
A topic guide was used to structure the interviews (Table 3). All interviews were 
audiotaped.  
 
Analysis 
All interviews were transcribed by MB and NVivo 10 was used to manage the 
transcripts and data coding. Inductive thematic analysis using a grounded approach 
was adopted [27]. Initially, all transcripts were read carefully to identify sections of text 
relevant to service users’ experience of SDS or control arm. LT analysed the 
transcripts for each interview separately and generated initial codes from the relevant 
data using open coding. Emerging codes were tested and modified by constant 
comparison. Coded data were then collated into broader themes and sub-themes, 
which were reviewed with other members of the research team (RM, CKH, AG), before 
the definition and labelling of each theme were agreed upon. Quotations were selected 
to illustrate each theme. 
 
 
 
 
Results 
 
Four main themes emerged from the data that related to service user experience: 
specific treatment components of the SDS; the individual qualities of clinicians; the 
collaborative team approach; and the accessibility of the SDS treatments..  
 
Treatment Components of the SDS 
Participants were able to identify specific elements of the treatment that participants 
had received from clinicians delivering the SDS that had been particularly effective or 
different from their experiences of previous treatment. The sub-themes that emerged 
described those elements of the SDS treatments that participants had valued. 
 
Management of Medication Changes 
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Participants who had received the SDS commented on the efficiency and clarity of any 
medication changes that were made during their treatment. Any changes to medication 
were discussed, and different options explained, so that the service user felt informed 
and engaged with the decision-making. 
“not only did she make suggestions but she explained kind of a route 
through so it is like ‘well we can try this, but if this doesn't work then we have 
got other options and …. which way do you think would be best to go first?’ 
and so you kind of knew more where you were” SU2 (SDS) 
 
Furthermore, any changes made to medication through the Specialist Depression 
Service were very rapidly implemented, and avoided delays that had been commonly 
experienced in previous treatments. 
“if they said we want to change it, you would change it then it would happen that 
day” SU1 (SDS) 
 
Explaining and Developing Treatment Strategies 
Participants described the positive experience of clinicians explaining aspects of their 
depression, medication and therapies to them as part of their treatment within the 
SDS. They gained benefits from feeling more informed about and developing a more 
objective view of their condition. 
“there is stuff I don't know and stuff I don't understand and he will explain it to me, 
he will get a flipchart out right I will show you. This is how your brain works this is 
what that does if you feel like that, it triggers that and it's wonderful, and I like just 
being able to understand it makes me feel a lot better….. he helps me to have 
some objective view of myself” SU21 (SDS) 
 
This understanding supported the participants to use the cognitive behavioural 
strategies more effectively after the trial had ended. 
“I feel I have been struggling a bit since I finished but... but then I worked out my 
own sheets, where I chart my mood every day …. So as soon as [my mood] starts 
to drop I try and be on it and do something about it.” SU25 (SDS) 
 
In comparison, those in the TAU arm described a cycle of routine appointments that 
did not engage them in their treatment and gave them no optimism for the future. 
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“my current a doctor once every 3 months…. Once every 3 months.  … That is no 
help.  It is just keeping the paperwork up to speed isn't it” SU12 (TAU) 
 
 
Setting Realistic Expectations 
Participants described gaining a more realistic expectation of what their recovery might 
look like through their interactions with clinicians from the SDS. This largely concerned 
adjusting their assumptions that recovery meant being free from symptoms and no 
longer taking medication. Participants receiving the SDS described how they had 
accepted that periods of depression may still occur and that they may need to stay on 
some form of medication for the longer term. 
“I always assumed that I would get better and that would mean not being on tablets.  
… I think I spent time with [clinician], really, he’s got me used to the idea that I will 
probably be on something to keep me level in the long term.  I think I’ve just about 
got used to that idea now.  Whereas before, it was just completely out of the 
question.” SU15 (SDS) 
 
 
A Person-Centred Approach 
Clinicians delivering the SDS provided an individualised and person-centred approach 
to service users. This was characterised by asking service users about their needs 
and allowing them to take the lead in setting the agenda and focus for the sessions. 
 
 
“I am asked what I want to talk about at the beginning of every session, what do I 
think will help me, what do I want, what is making me unhappy, you know what is 
working for me so, …. it is different, it's very different and a little disconcerting at 
first” SU21 (SDS) 
 
In contrast, participants in the TAU arm had not experienced this individualised, 
tailored approach and expressed frustration that their treatment did not address their 
individual needs. 
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“we are not all the same, yes we might be suffering from the same symptoms but 
we are all different people, and we all need handling in different ways” SU30 
(TAU) 
 
A Holistic Approach 
Related to this focus on the individual person, the service users also experienced a 
more holistic approach from clinicians in the SDS. Participants found that the clinicians 
were interested in their overall well-being and quality of life, including physical health, 
social activity and employment, rather than just their mental health. Clinicians provided 
practical help in accessing physiotherapy, attending social groups and gaining benefits 
advice. This was in contrast to participants’ experience of previous treatments which 
had solely focused on their mental health. Service users also reflected that they had 
learnt how inter-related their mental health was with other aspects of their health and 
life. 
“The fact that they looked at all of my health sort of mental and physical because 
the two are intertwined I mean they can't be separated ... and I have understood 
more clearly that that is the case since I have been on the study. That was 
something that was never looked at before, so all that the people before were 
concerned about was the mental health side of things, and I wasn't even asked 
about any of the physical health or anything like that.” SU2 (SDS) 
 
 
Individual Qualities of SDS clinicians 
In addition to specific elements of the treatment that they had received through the 
SDS, participants described the personal qualities and behaviours of individual 
clinicians as being important aspects of their experience of the service. A range of 
qualities were described by participants including: being calm and relaxed, empathetic, 
non-judgemental, re-assuring, positive, and having the ability to get people to open 
up.  This last quality was particularly highlighted by participants and contrasted with 
their previous experience of treatments. Participants described developing a 
connection with the clinicians, allowing them to open up and trust their clinicians which 
they believed had helped with their engagement with the treatment.   
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I find this a lot better, … I have been able to open up more... probably share more 
things than I ever have shared any before ... I don't know whether it's because of 
this particular [clinician] the way she is, has... worked with me and allowed me to 
open up …. I found I have been able to talk openly and honestly with her.” SU8 
(SDS) 
 
The importance of making a positive and trusting connection with a clinician was 
highlighted by one participant from the TAU arm of the study who had not experienced 
a positive working relationship. 
“I think it was of limited use because I didn't get on with the therapist…. she 
wasn't somebody I could really open up to, or talk to, I guess you know I didn't 
trust her …. just not somebody I felt comfortable [with]… because I didn't feel 
that she got me or understood me or whatever so, you know that puts a barrier 
between you kind of opening up.”  SU17 (TAU) 
 
In contrast, a few participants in the TAU arm did experience a more positive 
relationship with their clinicians, and found this beneficial to their treatment. 
“she was the only one really that I think understood... I really was grateful because 
the understanding has never been there before if you know what I mean” SU23 
(TAU) 
 
A Collaborative Team Context 
Service users who had experienced the SDS were able to articulate the differences in 
their treatment due to the collaborative team approach. These focused on two main 
aspects: improved communication between healthcare professionals, and continuity 
amongst team members. 
 
Communication between Healthcare Professionals 
It was obvious to service users that the clinicians involved in the treatment had been 
sharing information and discussing aspects of their treatment. The knowledge that the 
clinical team were all talking to each other about the service users’ treatment was 
identified as significantly different from previous experiences, and gave service users 
confidence in the approach to their treatment, and that all clinicians involved were fully 
informed about other aspects of their treatment. 
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“They seem to work so well as a team, … I can speak to someone like [therapist] 
and I will see [psychiatrist] two or three weeks later and she will speak to me 
about what [therapist] said, so I know it gets passed on, I know they are all talking 
to each other. SU16 (SDS) 
 
In contrast, participants in the TAU arm were not confident about the exchange of 
information between different clinicians that may be involved in their care. 
“I have only got my psychiatrist really to talk to, and he was showing me ways 
by getting in touch with a separate organisation to, but then they won't be talking 
to him to kind of you know [about me]” SU29 (TAU)  
 
Continuity of Team Members 
Having clinical team members that were consistent and unchanged throughout the 
study was also experienced as something quite different from previous treatments and 
the TAU arm. This continuity was described as being beneficial to developing trust and 
confidence in the clinicians, which in turn benefitted their engagement with treatment. 
“I think the most important factors are the continuation of the same people, and 
the distinction between their different roles… It give me confidence in them.” SU2 
(SDS) 
 
In contrast, the TAU participants described the impact of seeing different clinicians 
during treatments, both during the study and through prior experience. Many 
participants from both arms of the study described their previous experiences of 
constantly changing psychiatrists and the frustrations of having to retell their 
experiences from the beginning on multiple occasions. In addition, the uncertainty and 
concern that was experienced due to changing clinicians was felt to be particularly 
damaging for people with depression. 
“change for me isn't a good thing because I have to reset all my, or rearrange all 
my parameters … what makes me feel safe and stuff, so seeing somebody new 
… in general was a problem” SU30 (TAU) 
 
Accessibility to SDS 
Participants who had experienced the SDS described the benefits of an easily and 
frequently accessed service. 
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Access outside appointment times 
Participants felt reassured that they could access the service to make additional 
appointments to those already made if they needed to. In reality, they rarely made 
additional appointments but the knowledge that this was available appears sufficient 
to convey some benefit to the service users. 
“knowing that if things were bad, I could phone her up and get an urgent 
appointment with her, was more valuable than actually doing it to be honest.  … 
I can't stress enough how important that is, really important.” SU24 (SDS) 
 
This contrasted sharply with the experience of participants in the TAU arm who 
described the challenges of getting earlier appointments or talking to someone 
between appointments, and negative impact of having an service unresponsive to the 
needs of services users at critical times. 
“It is like trying to get into Fort Knox, to try and maybe get an earlier appointment. 
I have rung the secretary and said ‘I really could do with...’ By the time I get one 
it's my appointment time anyway.” SU8 (TAU) 
 
Flexible locations 
A number of participants described the benefits of being able to have consultations 
take place in their homes. This flexibility provided both reassurance and a sense of 
safety to the service users who had requested this. But one participant also thought it 
gave the clinician some additional insights into the service user’s state of mental 
health. 
It's been really, really good that she has come to me most of the time at home, 
because that's, that is really significant actually…. I would think it helps [the 
clinician]... because she can see at any given time how well I am kind of looking 
after things,... she has definitely seen it in various states, but also just for her to 
know the environment in which I am in.” SU2 (SDS) 
 
Frequent Consultations 
Participants reported that the frequent and ongoing consultations in the SDS was of 
benefit to them. They felt that their treatment was very proactive with more time 
invested by clinicians. This was particularly important in relation to their application of 
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CBT techniques and skills learnt in consultations, and the need to reminders and 
reinforcement of the techniques learnt. 
“There were a couple of times where I was on holiday or [the clinician] was on 
holiday and you know it was two weeks [between appointments] and it just gives 
you that much time to slip back a bit. Whereas if you have got a week, you can 
keep it in your head and you can work on whatever the ideas that you are working 
on.  And then remember it and feedback, quite effectively. SU24 (SDS) 
 
By the end of the trial some service users reported a decline when the frequent 
consultations had stopped, again pointing to the benefits of having regular reminders 
of the CBT techniques 
“I’m almost a year out of the project now and I can feel I’m slowly slipping back 
down again.  But there’s more regular times on the [trial] and that year afterwards.  
It did away with all of that and I did feel there was some hope.”  SU15 (SDS) 
 
In contrast, service users in the TAU described how the infrequent sessions and time-
limited nature of the service prevented them making progress, largely through the 
additional time taken to build an effective therapeutic relationship. 
“you are talking about 4 or 5 almost 6 sessions to really start trusting somebody 
because each time they chip away at you and you, you let a bit out and you are 
still guarded and yes, so you are talking what 3 months say, you know before you 
are really opening up completely. And obviously you are not going to get 
anywhere unless you open up to these people, you are not going to get any 
better” SU29 (TAU) 
 
Gradual Pace of Treatment 
Participants receiving the SDS frequently reported that the 12 month duration of 
treatment  allowed a better pace to be established. Participants didn’t feel rushed 
which in turn led to better engagement, and more established recovery allowing 
service users to recover better from periods of depression. 
“you can do it so rigorously when it's once a week for a whole year it's really, it 
just becomes part of like the foundation, the missing bits of foundation.  And then 
it's I don't know it's just there for you to fall back on” SU25 SDS 
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Having time to get service users to the point at which they can start to fully engage 
with the treatment and the CBT techniques was seen as one of the benefits of a longer 
treatment cycle. A participants receiving the Treatment as Usual arm described this in 
relation to time-limited therapy sessions. 
 “you get your 20 sessions or your 10 sessions or whatever, [but] what if you are 
in a state where it takes 6 or 7 sessions to get to the point where you can 
intellectually connect with the process and really do it properly…. And it doesn't 
have time to take effect and yes it gets you out of the, being in a pit of misery but 
it doesn't stop you going back into it the next time something horrendous 
happens.” SU24 TAU 
 
Challenge of Returning to TAU 
Some participants who had received the SDS found the transition back to the usual 
frequency of appointments a difficult process. Moving from the enhanced accessibility 
and frequency of their treatment in the SDS arm of the trial to the more infrequent 
sessions experienced in usual care and also meant that they were subject to the 
difficulties of cancelled appointments and changing clinicians.  
“Well I mean that was appalling really in the sense that you know you have been 
seeing somebody regularly and trustworthingly…, you then got referred back to 
your GP basically and the mental health services ….[and that appointment was 
cancelled] so it was 4, nearly 4 or 5 months or something in that order before I 
next saw a... mental health professional” SU1 (SDS) 
 
Participants also missed the frequent contact with clinicians and described how they 
need to be more proactive in their own use of the CBT techniques. 
“CBT teaches you to almost not have to go tell people things doesn't it, it's like 
you are your own sort of mentor aren't you but, I think there is also part of me 
needs to just talk things over with somebody from time to time I think…  But, I 
just lost my objectivity a bit, … So maybe if I just had a chat with someone at 3 
months perhaps” SU25 (SDS) 
 
Further difficulties were experienced by participants due to lack of clear 
communication about the end of the trial and the transition back to usual care.  
15 
 
“I didn’t realise my last session with him was my last session…  And he came 
in and said, last one. And I just burst into tears.  But that was, I was scared, I 
thought I wasn’t going to have that one last throw of the dice, if you like. ” SU15 
(SDS) 
 
However, the longer-term impact of the SDS was reported by some of the participants.  
But there’s more regular times on the [trial] and that year afterwards, …..  It did 
away with all of that and I did feel there was some hope.  SU15 (SDS) 
 
Discussion 
The service user experience of the SDS was very positive, and participants were able 
to articulate elements of the service which differed from their previous experiences of 
treatment, and why they were beneficial to them. Participants felt informed and 
engaged in the different elements of their treatment, both in relation to their CBT and 
their medication.  In the SDS, participants felt that different options were explained and 
set out, and that they had some control in setting the agenda and having their 
individual needs addressed. This included having clinicians help with other aspects of 
their well-being and quality of life. Having realistic expectations about what their 
recovery might look like was another important element of the SDS that participants 
experienced. This frequently involved accepting that it might be necessary to stay on 
some form of medication and that depression symptoms may reoccur. Many of these 
elements align themselves with recovery-focused practices which aim to achieve 
service user defined goals and outcomes to build a meaningful and satisfying life that 
is not necessarily symptom free [28]. 
 
The personal qualities of clinicians were also highlighted as an important element of 
effective treatment, particularly in developing trust and encouraging the participants to 
open up to the clinicians. This wasn’t unique to the SDS arm, and similar qualities were 
experienced by people in the TAU arm too. This finding highlights the benefits of 
developing positive working relationships between service users and mental health 
professionals, as has been identified in other studies [22, 29].  
 
Aspects of the SDS collaborative team working were also identified by participants as 
beneficial feature of their treatment that they had not experienced before. Participants 
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gained confidence in the knowledge that the different clinicians involved in their 
treatment were communicating effectively with each other, and informed about the 
different aspects of treatment. The continuity of team members throughout treatment 
further enhanced this communication and also supported the development of trust 
between clinicians and service users, resulting in better engagement. This was sharply 
contrasted by the participants’ previous experience of frequent changes to clinicians 
and the negative impact this had on their treatment. 
 
Finally, participants described the benefits they experienced from the ease and 
frequency of access to the SDS. Although they rarely accessed the service outside of 
their booked appointments, knowing that it was possible to get earlier appointments 
reassured the service users. Having appointments at home was also perceived to be 
beneficial for a number of participants. For the CBT part of the service, the frequency 
of consultations and total length of treatment were both highlighted by participants as 
important factors that contrasted with their previous experience of treatment. Frequent 
CBT sessions helped participants to reinforce the techniques used, and avoid slipping 
back into their usual ways of thinking. Similarly, having a sufficient number of CBT 
sessions was repeatedly stressed as being important to allow service users to fully 
engage with the therapy, develop trusting relationship with the clinician and establish 
the techniques to support their prolonged recovery. The importance to service users 
of the appropriate timing of treatment which coincides with their own readiness has 
been found in other studies [22, 30].   
 
Although the frequency of consultations experienced by participants in the SDS arm 
of the trial was perceived by them as one of the benefits of this approach, this also 
resulted in some challenges for participants once they returned to treatment as usual 
when the trial had finished. The transition into usual care was difficult for some 
participants to adjust to. However, there was evidence from the service user interviews 
in the SDS arm of changes in attitudes to treatment and coping strategies indicating 
lasting improvement in coping with this long-lasting and recurrent condition. 
 
 
Strengths and Limitations 
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Qualitative methods were used in this study to explore and understand the 
experiences of service users with long experience of mental health services to provide 
additional insights into the mechanisms of action of the SDS on depression symptoms 
versus TAU. Important aspects of care can be identified in a complex intervention such 
as a service intervention that are difficult to capture otherwise.  Most RCTs of single 
pharmacological or psychological treatment interventions can explore the process of 
care delivery through simple methods such as prescribed medication and therapist 
competency but care in services covers many interdependent therapeutic approaches 
delivered by many different staff.   
 
Whilst this approach enables greater depth of understanding of service user 
experience, the generalisability of findings is limited by nature of the sample, which is 
both small and self-selecting. We did not have interviews with patients who dropped 
out early from the SDS and may have had much more negative experiences of such 
treatment. The contrast between the SDS and TAU may be more or less marked if 
usual care in specialist general mental health services as fewer or more features in 
common with SDS care outlined here. Furthermore service user experience may not 
reflect accurately important aspects of care that is technical in nature. It also did not 
provide insight into the non-significant effects of SDS on functional outcomes as 
opposed to the effectiveness on depression symptoms.   
 
Implications for Practice 
Service users highlighted the benefits of features of the SDS service which were 
different from their previous experiences of treatment and those in the control arm. 
Participants positive experience of the SDS centred around the ability to develop 
trusting relationships with therapists working in a stable and collaborative team, the 
frequency and accessibility of sessions and the ability to top-up and reinforce the 
techniques learnt over a longer period. In addition, having a sufficiently long treatment 
period to foster the development of trust and positive relationships is important; service 
users should not feel rushed. Participants spoke about the importance of being able 
to engage with the therapists which required building up trust and connections. The 
need for a gradual pace and length of treatment was reflected in the outcome 
measures of the RCT where there was no difference between the arms in any outcome 
measure until 6 months and significance on the primary HDRS outcome measure was 
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not reached until 18 months [8]. Time-limited CBT sessions will not achieve these 
factors that were widely considered to be most beneficial. These findings concur with 
other studies which have demonstrated that short-term therapies are insufficient in 
leading to recovery. A meta-analysis of six trials comparing short-form psychodynamic 
psychotherapy with CBT for depression found that 16-20 sessions of either therapy 
was insufficient to achieve a long-term remission for patients [15]. A more recent trial 
[16] also found that more than 16 sessions of either CBT or psychodynamic supportive 
therapy were needed to achieve remission in patients attending outpatients’ clinics. 
Together, these findings suggest the future design of services for people with recurrent 
depression should aim to foster a longer-term and collaborative approach to building 
therapeutic relationships. 
 
Conclusions 
This study provided in-depth qualitative data about service users’ experience of the 
SDS, how it differed from their previous experiences of treatment, and why this was 
beneficial to them. The findings highlight the importance of some of the specific 
treatment components of the SDS model, such as the careful management of 
medication change, taking time to explain treatment strategies, setting realistic 
expectations in relation to recovery, and using a person-centred and holistic approach. 
In addition, the individual qualities of clinicians were highlighted as important in 
developing trust with service users, which promoted better engagement with clinicians. 
The collaborative nature of the SDS team provided a context of effective 
communication and continuity within the team, which further promoted confidence 
amongst service users. Finally, frequent consultations and ease of access supported 
the experience of service users, allowing them to engage in therapy at their own pace. 
However, the frequency of consultations also resulted in some challenges for 
participants once they returned to treatment as usual when the trial had finished. The 
transition into usual care was difficult for some participants to adjust to. However, there 
was evidence from the service user interviews in the SDS arm of changes in attitudes 
to treatment and coping strategies indicating lasting improvement in coping with this 
long-lasting and recurrent condition. 
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Figure 1. CONSORT diagram showing flow of participants through the RCT with 
timing of qualitative interviews added. 
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Table 1: Baseline characteristics of the main RCT sample, outcomes and care 
received. 
 
 
*SDS significantly more effective than TAU p=0.015 
**SDS non-significantly more effective than TAU, p=0.113 
SDS = Specialist Depression Service; TAU = treatment as usual 
1 Other employment: part-time, sheltered and voluntary employment and higher education 
HDRS17 = 17 item Hamilton Depression Rating Scale 
GAF = Global Assessment of Function 
 
 
 
 
 
 
 
 
 
 
TAU SDS 
(n = 94) (n=93) 
Age, mean (sd,) 46 (11.3) 47 (11.6)  
Gender, female, n (%) 60 (64) 54 (58)  
Employment status, n (%) 
full-time employment 
[n=91] [n=90] 
22 (26) 17 (19) 
Other employment1 11 (12) 10 (11) 
Retired 10 (11) 16 (18) 
Unemployed 37 (41) 36 (40) 
Married or co-habiting, n (%) 50 (53) 42 (45) 
Years since first diagnosis of depression  mean 
(sd) 
16.9 (11.6) 16.5 (11.1) 
Depressed > 1 year, n (%) 82 (87) 80 (86) 
HDRS17, baseline mean (sd) 
6 month mean (95% CI) drop 
12 month mean (95% CI) drop 
18 month mean (95% CI drop)* 
23.2 (5.8) 
-3.76(-5.45, -2.07) 
-4.99(-7.04, -2.94) 
-6.00(-8.13, -3.87) 
22.0 (4.5) 
-4.77(-6.32, -3.22) 
-7.44(-8.98, -5.90) 
-8.96(-10.64, -7.28) 
GAF, baseline mean (sd) 
6 month mean (95% CI) gain 
12 month mean (95% CI ) gain 
18 month mean (95% CI) gain** 
47.7 (9.4) 
4.61(1.51, 7.70) 
5.14(1.99, 8.28) 
5.60(2.17, 9.03) 
49.3 (6.8) 
5.93(3.08, 8.79) 
9.26(6.31, 12.21) 
9.42(6.53, 12.31) 
Median (range)  number of appointments  
with psychiatrist, 0-18 months 
with psychotherapist, 0-18 month  
 
8 (0-45) 
4.5 (0-49) 
 
17 (0-92) 
18 (0-67) 
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Table 2. Demographic and clinical characteristics of the qualitative sample 
UIC Site Arm of the 
Study 
Completed Treatment 
(6m+) 
Follow Ups Completed 
(up to 24 months +) 
HRSD 
baseline 
HRSD 
18months 
       
SU15 N SDS Yes Yes 21 23 
SU1 N SDS Yes Yes 20 11 
SU24 N SDS Yes Yes 24 1 
SU27 N SDS Yes Yes 24 6 
SU7 N SDS Yes Yes 27 10 
SU25 N SDS Yes Yes 17 5 
SU11 N TAU N/A Yes 16 18 
SU12 N TAU N/A Yes 25 24 
SU17 N TAU N/A Yes 16 6 
SU23 N TAU N/A Yes 27 19 
SU2 C SDS Yes Yes 25 12 
SU19 C SDS Yes Yes 20 18 
SU16 C SDS Yes Yes 22 3 
SU29 C TAU N/A Yes 26 22 
SU30 C TAU N/A Yes 19 14 
SU21 D SDS Yes Yes 16 8 
SU4 D SDS Yes Up to 12m 19 DNC 
SU8 D SDS Yes Yes 24 25 
SU6 D TAU N/A Yes 18 29 
SU18 D TAU N/A Up to 18m 19 18 
SU26 D TAU N/A Up to 18m 18 20 
 
N= Nottingham, C=Cambridge, D =Derby; SDS= Specialist Depression Service, TAU = treatment as 
usual; HDRS= 17-item Hamilton Depression Rating Scale; DNC = Did Not Complete 
Completed Treatment: Completed up to 6m or more.  
Time of interview: Interview was conducted after this time point 
 
 
 
Table 3. Interview Topic Guide 
1. What can you tell me how you became involved in this research? 
 Who told you about it 
 How they told you 
 Why you wanted to be part of this research 
 
2. Can you tell me why this research is needed?  
 What does this service offer now?  
 Do you know what the desired outcome of the research is? 
 
3. Do you have views on how you would like the service here to change? 
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4. Do you know who is involved in this research, which doctors, nurses or other 
people? 
 
5. What are you hoping to get from your involvement with the research/service?  
 
6. In addition to the services you receive here, do you take any other steps to re-
lieve your symptoms? 
 
7. Could involvement in this research lead you to do anything different? 
 
8. Have you seen changes in the service since you first became a service user?   
 
9. Do you know what has helped to make change happen? (give examples) 
 
10. Or got in the way of change happening? (give examples) 
 
11. Looking at the research and the efforts to improve the service, are there any 
things you would have liked to see done differently? 
 
12. Is there anything else that you would like to tell me?   
 
 
